Company Profile

Theragnostic Technologies Inc
Profile last edited on: 12/4/2019      CAGE: 5ELR3      UEI: Y34HJHHKC2C6

Business Identifier: Novel MRI contrast agent
Year Founded
2012
First Award
2013
Latest Award
2019
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

25 Health Sciences Drive Unit 128
Stony Brook, NY 11790
Location: Single
Congr. District: 01
County: Suffolk

Public Profile

Theragnostic Technologies is a seed stage biomedical company focused on high performance multifunctional nanotechnology-enabled materials and devices having ties to Stonybrook University. Describing the firm as working on customizable nano-carrier platforms for next-generation integrated diagnostic & therapeutic medicine, Principals of the firm operate a nano-technology carrier platform intended to undertake R&D involving high performance multifunctional nanotechnology-enabled materials and devices. The initial effort involved development of multifunctional nanotechnology-based products for diagnostic, therapeutic & regenerative medicine. First product ManGraDex was an MRI contrast agent. Services offered included a range of cutting-edge biomedical and healthcare products to improve imaging, therapy and tissue regeneration, enabling medical researchers to generate a diversified product pipeline for diagnostic, therapeutic and regenerative medicine.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Key People / Management

  Balaji Sitharaman

  Jimmy D Toussaint

Company News

There are no news available.